Understand the source comparison
LIPO-C Methionine Protocols: Comparison of Administration Variables
Dosing Frequency 2–3× per week Daily (5–7× per week) 1× per week Standard protocol balances methionine turnover (72-hour cycle) with injection site recovery. Most research models use this cadence Methionine per Dose 25–50 mg 15–25 mg 75–100 mg Doses above 50 m
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dosing Frequency
- 2–3× per week
- Daily (5–7× per week)
- 1× per week
- Standard protocol balances methionine turnover (72-hour cycle) with injection site recovery. Most research models use this cadence
- Methionine per Dose
- 25–50 mg
- 15–25 mg
- 75–100 mg
- Doses above 50 mg show diminishing returns due to MAT enzyme saturation. High-frequency protocols use lower per-dose amounts to stay within enzymatic capacity
- Injection Depth
- Subcutaneous (4–8 mm)
- Intramuscular (12–25 mm)
- Subcutaneous administration provides sustained release over 48–72 hours; IM creates faster peak but shorter duration. Use SC unless IM is specifically required
- Reconstitution Stability
- 28 days at 2–8°C
- Single reconstitution per use
- Pre-mixed solutions degrade predictably. Single-use reconstitution eliminates storage variables but increases handling complexity
- Target Pathway
- Hepatic lipid metabolism
- Insulin signaling modulation
- SAMe pathway saturation
- Standard protocol optimizes for phosphatidylcholine synthesis; high-frequency targets insulin-mediated lipid packaging; single-dose is experimental